Deep Track Capital, LP
- SEC CIK
- 0001856083
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 61
- −8 vs. Q3 2024
- Portfolio value
- $2.67B
- −$465.1M (−14.8%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DVAXDynavax Technologies Corp | COM NEW | 17,791,486 | $227.2M | 8.5% | +5,265,000+42.0% | Added | History |
| GHGuardant Health, Inc. | COM | 6,419,566 | $196.1M | 7.4% | +419,006+7.0% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $167.0M | 6.3% | +399,307+24.9% | Added | History |
| IMVTImmunovant, Inc. | COM | 6,000,000 | $148.6M | 5.6% | +1,652,536+38.0% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,274,921 | $136.4M | 5.1% | −125,733−2.9% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,460,756 | $125.0M | 4.7% | −383,144−10.0% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 2,500,000 | $117.6M | 4.4% | +1,870,094+296.9% | Added | History |
| OCULOcular Therapeutix, Inc | COM | 12,836,282 | $109.6M | 4.1% | +114,822+0.9% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 4,522,741 | $86.7M | 3.3% | +771,796+20.6% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,972,257 | $78.7M | 2.9% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 2,800,000 | $75.9M | 2.8% | +1,579,492+129.4% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 1,933,928 | $67.6M | 2.5% | −266,072−12.1% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 3,000,000 | $56.5M | 2.1% | −868,104−22.4% | Reduced | History |
| MBXMBX Biosciences, Inc. | COM | 3,018,935 | $55.6M | 2.1% | 00.0% | Unchanged | History |
| ETNB89bio, Inc. | COM | 6,478,249 | $50.7M | 1.9% | +3,711,737+134.2% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,450,000 | $49.9M | 1.9% | +1,450,000 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $47.1M | 1.8% | −1,282,000−39.1% | Reduced | History |
| SEPNSepterna, Inc. | COM | 1,912,929 | $43.8M | 1.6% | +1,912,929 | New | History |
| NMRANeumora Therapeutics, Inc. | COM | 4,000,000 | $42.4M | 1.6% | +3,432,572+604.9% | Added | History |
| GMABGenmab A/S | SPONSORED ADS | 2,000,000 | $41.7M | 1.6% | +2,000,000 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 1,490,000 | $41.5M | 1.6% | +800,216+116.0% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 850,000 | $39.5M | 1.5% | −2,330,025−73.3% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,540,132 | $38.9M | 1.5% | +1,540,132 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 1,000,000 | $38.6M | 1.4% | +1,000,000 | New | History |
| ANIPAni Pharmaceuticals Inc | COM | 649,042 | $35.9M | 1.3% | +144,214+28.6% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 2,000,000 | $34.8M | 1.3% | +1,203,148+151.0% | Added | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 14,218,903 | $33.4M | 1.3% | −1,053,269−6.9% | Reduced | History |
| KRROKorro Bio, Inc. | COM | 874,614 | $33.3M | 1.2% | +24,614+2.9% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 5,576,558 | $30.9M | 1.2% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 4,557,575 | $30.3M | 1.1% | +1,949,942+74.8% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 653,513 | $27.5M | 1.0% | +653,513 | New | History |
| ABVXAbivax S.A. | SPONSORED ADS | 3,579,209 | $26.2M | 1.0% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,350,000 | $22.6M | 0.8% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 819,162 | $22.5M | 0.8% | +819,162 | New | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 780,778 | $21.5M | 0.8% | +780,778 | New | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,442,833 | $20.1M | 0.8% | −557,167−13.9% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 2,816,594 | $19.6M | 0.7% | −4,248,505−60.1% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 710,421 | $19.0M | 0.7% | −390,115−35.4% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,276,081 | $17.9M | 0.7% | −2,271,920−64.0% | Reduced | History |
| UPBUpstream Bio, Inc. | COM | 1,000,000 | $16.4M | 0.6% | +1,000,000 | New | History |
| NVAXNovavax Inc | COM NEW | 2,000,000 | $16.1M | 0.6% | +2,000,000 | New | History |
| IMCRImmunocore Holdings plc | ADS | 519,376 | $15.3M | 0.6% | +519,376 | New | History |
| ORKAOruka Therapeutics, Inc. | COM | 750,000 | $14.5M | 0.5% | −485,187−39.3% | Reduced | History |
| GERNGeron Corp | COM | 4,011,287 | $14.2M | 0.5% | −3,563,762−47.0% | Reduced | History |
| HELPCybin Inc. | COM NEW | 1,529,987 | $13.5M | 0.5% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 500,000 | $11.5M | 0.4% | −300,000−37.5% | Reduced | History |
| ALGSAligos Therapeutics, Inc. | COM NEW | 244,110 | $9.73M | 0.4% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 6,011,380 | $9.50M | 0.4% | +6,011,380 | New | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $8.21M | 0.3% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $7.79M | 0.3% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 5,704,282 | $6.90M | 0.3% | +704,282+14.1% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 169,132 | $6.63M | 0.2% | +169,132 | New | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 867,000 | $6.44M | 0.2% | −100,000−10.3% | Reduced | History |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 3,119,162 | $5.71M | 0.2% | +1,314,796+72.9% | Added | History |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $5.15M | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 219,015 | $5.10M | 0.2% | −780,985−78.1% | Reduced | History |
| IVVDInvivyd, Inc. | COM | 10,689,603 | $4.74M | 0.2% | −264,334−2.4% | Reduced | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 523,989 | $4.51M | 0.2% | +523,989 | New | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 609,900 | $3.40M | 0.1% | −3,486,552−85.1% | Reduced | History |
| CLYMClimb Bio, Inc. | COM | 1,040,115 | $1.87M | 0.1% | −1,129,028−52.0% | Reduced | History |
| NKTRNektar Therapeutics | COM | 1,975,998 | $1.84M | 0.1% | −13,946,657−87.6% | Reduced | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2024 (22)
Positions held at the end of Q3 2024 that are gone from this filing.
| Security | Class | Shares in Q3 2024 | Value in Q3 2024 | % of portfolio in Q3 2024 | History |
|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 365,000 | $197.9M | 6.3% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 4,950,000 | $101.7M | 3.2% | History |
| ALKSAlkermes plc. | SHS | 3,500,000 | $98.0M | 3.1% | History |
| AXSMAxsome Therapeutics, Inc. | COM | 857,219 | $77.0M | 2.5% | History |
| APGEApogee Therapeutics, Inc. | COM | 1,000,000 | $58.7M | 1.9% | History |
| TGTXTG Therapeutics, Inc. | COM | 1,725,000 | $40.3M | 1.3% | History |
| KURAKura Oncology, Inc. | COM | 1,963,505 | $38.4M | 1.2% | History |
| KYMRKymera Therapeutics, Inc. | COM | 600,326 | $28.4M | 0.9% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 475,000 | $21.8M | 0.7% | – |
| ALECAlector, Inc. | COM | 4,631,998 | $21.6M | 0.7% | History |
| FATEFate Therapeutics Inc | COM | 5,572,607 | $19.5M | 0.6% | History |
| SLNSilence Therapeutics plc | ADS | 1,000,000 | $18.2M | 0.6% | History |
| EDITEditas Medicine, Inc. | COM | 4,900,334 | $16.7M | 0.5% | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 4,184,100 | $15.4M | 0.5% | History |
| TVTXTravere Therapeutics, Inc. | COM | 531,857 | $7.44M | 0.2% | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,553,996 | $5.28M | 0.2% | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 219,648 | $2.51M | 0.1% | History |
| PRTAProthena Corp Public Ltd Co | SHS | 140,000 | $2.34M | 0.1% | History |
| RLMDRelmada Therapeutics, Inc. | COM | 674,833 | $2.19M | 0.1% | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $1.78M | 0.1% | History |
| MGXMetagenomi Therapeutics, Inc. | COM | 307,500 | $667.3K | <0.1% | History |
| SRRKScholar Rock Holding Corp | COM | 48,100 | $385.3K | <0.1% | History |